Skip to content

Study · Non-randomized trial · n = 194 · 1990

2 results

Nafarelin versus danazol in the treatment of endometriosis.

Rolland R, van der Heijden PF

American journal of obstetrics and gynecology1 Feb 1990Cited by 25 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In women with endometriosis, nafarelin and danazol produced comparable decreases in American Fertility Society scores.

    In plain wordsIn women with endometriosis, nafarelin and danazol reduced disease scores similarly.

    Peptide
    Nafarelin
    Outcome
    Direction not reportedAmerican Fertility Society endometriosis score
    Study

    n = 194

    Comparator
    Danazol 200 mg twice daily
    Outcome group
    Organ injury · Reproductive and sexual health
    Studied dose
    200 micrograms twice daily · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    A comparison of decreases in both groups of American Fertility Society endometriosis scores and in severity scores developed by the investigators indicates that nafarelin and danazol are equally effective in the treatment of endometriosis.
    4 context sentences
    Summary · context
    A double-blind, double-dummy, 6-month multicenter study comparing the effects of nafarelin and danazol in the treatment of endometriosis was completed recently by investigators from 13 institutions in seven European countries.
    Summary · context
    The 194 patients (aged 18 to 45 years) selected for the study were divided into two groups.
    Summary · context
    One group received nafarelin, 200 micrograms twice daily, and placebo capsules identical to danazol, twice daily.
    Summary · context
    The other group received danazol capsules, 200 mg twice daily, and a placebo nasal spray identical to nafarelin, twice daily.
  2. 02HumanNon-randomized trialEfficacy outcome

    In women with endometriosis, nafarelin and danazol produced comparable decreases in investigator severity scores.

    In plain wordsIn women with endometriosis, nafarelin and danazol reduced investigator severity scores similarly.

    Peptide
    Nafarelin
    Outcome
    Direction not reportedInvestigator severity score
    Study

    n = 194

    Comparator
    Danazol 200 mg twice daily
    Outcome group
    Organ injury · Reproductive and sexual health
    Studied dose
    200 micrograms twice daily · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    A comparison of decreases in both groups of American Fertility Society endometriosis scores and in severity scores developed by the investigators indicates that nafarelin and danazol are equally effective in the treatment of endometriosis.
    4 context sentences
    Summary · context
    A double-blind, double-dummy, 6-month multicenter study comparing the effects of nafarelin and danazol in the treatment of endometriosis was completed recently by investigators from 13 institutions in seven European countries.
    Summary · context
    The 194 patients (aged 18 to 45 years) selected for the study were divided into two groups.
    Summary · context
    One group received nafarelin, 200 micrograms twice daily, and placebo capsules identical to danazol, twice daily.
    Summary · context
    The other group received danazol capsules, 200 mg twice daily, and a placebo nasal spray identical to nafarelin, twice daily.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:36 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.